{"product_id":"tirzepatida-20-mg","title":"TIRZEPATIDE","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"text-align:justify;font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e is one of the most potent research peptides in the \u003cstrong\u003emetabolic and weight management\u003c\/strong\u003e field: it is being studied for its role in \u003cstrong\u003eappetite, blood sugar, and weight loss\u003c\/strong\u003e. Technically, it is a 39-amino acid peptide that acts as a dual GIP and GLP-1 receptor agonist (LY-3437943), the benchmark for the latest generation of incretins.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Glucose control and insulin sensitivity\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Appetite and satiety regulation\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body weight reduction and body composition\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Cardiometabolic markers\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and Rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003eContinuous until Goal\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003eNot required\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of Action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eDual Incretin Agonism (GIP \/ GLP-1)\u003c\/p\u003e\n\u003cp style=\"text-align:justify;margin:0 0 0.9em;line-height:1.6;\"\u003eIt combines the activation of the GLP-1 receptor (satiety and insulin secretion) with that of the GIP receptor (insulin sensitivity and lipid management), with a synergistic effect on glycemic control and weight.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eWeight reduction and glycemic control\u003c\/p\u003e\n\u003cp style=\"text-align:justify;margin:0 0 0.9em;line-height:1.6;\"\u003eThe sum of both mechanisms produces one of the most pronounced effects on body weight observed in clinical research.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eCardiometabolic outcomes\u003c\/p\u003e\n\u003cp style=\"text-align:justify;margin:0 0 0.9em;line-height:1.6;\"\u003eIts impact on blood pressure, lipid profile, and other cardiometabolic markers is being investigated.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific Evidence\u003c\/p\u003e\n\u003cp style=\"text-align:justify;margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eDual agonism (GIP\/GLP-1):\u003c\/strong\u003e Receptor studies confirm a balanced agonism, which is the basis of its metabolic potency.\u003c\/p\u003e\n\u003cp style=\"text-align:justify;margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eWeight and Glycemia:\u003c\/strong\u003e In the SURMOUNT-1 Phase 3 trial (NEJM, 2022), tirzepatide achieved weight reductions of up to ~20.9% at 72 weeks.\u003c\/p\u003e\n\u003cp style=\"text-align:justify;margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCardiometabolic:\u003c\/strong\u003e Clinical programs describe consistent improvements in metabolic parameters.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct Use\u003c\/p\u003e\n\u003cp style=\"text-align:justify;margin:0 0 0.9em;line-height:1.6;\"\u003eDue to its dual mechanism and outstanding clinical results, Tirzepatide is a top-tier reference material in metabolic and weight control research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we supply it as a high-purity peptide for laboratory use, with a certificate of analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"15 mg","offer_id":54603479777609,"sku":"TR15","price":192.5,"currency_code":"EUR","in_stock":true},{"title":"20 mg","offer_id":54545849286985,"sku":"TR20","price":219.0,"currency_code":"EUR","in_stock":true},{"title":"30 mg","offer_id":54603479810377,"sku":"TR30","price":252.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/tirzepatida-20-mg-sin-fondo.png?v=1782819734","url":"https:\/\/www.peptidobiogenetic.com\/en\/products\/tirzepatida-20-mg","provider":"PeptidoBioGenetic","version":"1.0","type":"link"}